Story perspectives
HIV Integrase Discovery Paves Way for Targeted Therapies
10/27/2025
1 of 1
Story summary
- Researchers at the Salk Institute used cryo-electron microscopy to reveal that HIV integrase shifts between a large 16-part complex for DNA integration and a smaller 4-part complex for RNA interaction.
- The discovery identifies dual functions of integrase as distinct targets for drug development to address drug resistance.
- The findings were published in Nature Communications.
- Future therapies could be personalized and more effective against HIV.
